Secondary Logo

Journal Logo

February 2017 - Volume 40 - Issue 1
pp: 1-108

ACR Appropriateness Criteria®

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

McLaughlin, Patrick W.; Liss, Adam L.; Nguyen, Paul L.; More

American Journal of Clinical Oncology. 40(1):1-10, February 2017.

Central Nervous System


Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study

Xing, Minzhi; Prajapati, Hasmukh J.; Dhanasekaran, Renumathy; More

American Journal of Clinical Oncology. 40(1):27-34, February 2017.

Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience

Khawaja, Muhammad R.; Kleyman, Svetlana; Yu, Zhangsheng; More

American Journal of Clinical Oncology. 40(1):42-46, February 2017.


Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors

Raggi, Daniele; Giannatempo, Patrizia; Miceli, Rosalba; More

American Journal of Clinical Oncology. 40(1):60-65, February 2017.


Soft Tissue

Head and Neck

Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases

Airoldi, Mario; Garzaro, Massimiliano; Pedani, Fulvia; More

American Journal of Clinical Oncology. 40(1):86-90, February 2017.

Cancer Management Controversy